- Home
- MLAB vs AQST Comparison
MLAB vs AQST Comparison
Compare MLAB & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- AQST
- Stock Information
- Founded
- MLAB 1982
- AQST 2004
- Country
- MLAB United States
- AQST United States
- Employees
- MLAB N/A
- AQST N/A
- Industry
- MLAB Industrial Machinery/Components
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- MLAB Industrials
- AQST Health Care
- Exchange
- MLAB Nasdaq
- AQST Nasdaq
- Market Cap
- MLAB 602.2M
- AQST 502.6M
- IPO Year
- MLAB N/A
- AQST 2018
- Fundamental
- Price
- MLAB $102.44
- AQST $4.41
- Analyst Decision
- MLAB Hold
- AQST Strong Buy
- Analyst Count
- MLAB 2
- AQST 7
- Target Price
- MLAB $140.00
- AQST $9.43
- AVG Volume (30 Days)
- MLAB 39.1K
- AQST 1.7M
- Earning Date
- MLAB 11-07-2024
- AQST 11-04-2024
- Dividend Yield
- MLAB 0.62%
- AQST N/A
- EPS Growth
- MLAB N/A
- AQST N/A
- EPS
- MLAB N/A
- AQST N/A
- Revenue
- MLAB $228,380,000.00
- AQST $58,900,000.00
- Revenue This Year
- MLAB $11.26
- AQST $18.45
- Revenue Next Year
- MLAB $5.27
- AQST N/A
- P/E Ratio
- MLAB N/A
- AQST N/A
- Revenue Growth
- MLAB 6.88
- AQST 22.56
- 52 Week Low
- MLAB $83.68
- AQST $1.69
- 52 Week High
- MLAB $141.17
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- MLAB 34.03
- AQST 37.69
- Support Level
- MLAB $113.26
- AQST $4.62
- Resistance Level
- MLAB $121.00
- AQST $5.59
- Average True Range (ATR)
- MLAB 5.99
- AQST 0.37
- MACD
- MLAB -1.65
- AQST -0.11
- Stochastic Oscillator
- MLAB 1.03
- AQST 2.54
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.